Editas MedicineEDIT

那斯達克 · USD
2.71
-0.28
(-9.36%)
收盤 06/06 03:59 (UTC+8)
06/06 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.60
  • 0.01
  • 0.01
  • 0.00
  • 0.31
  • 0.05
  • 0.04
  • 0.08
  • 0.25
  • 0.03
icon
  • 1025.36
  • -98.11
  • -54.71
  • -88.13
  • 50070.49
  • -84.78
  • -23.19
  • 110.82
  • 228.00
  • -88.56
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
營業收入淨額
2,831
24,741
7,543
3,578
4,658
30,604
61
514
1,135
60,049
營業成本
----------
營業毛利
2,831
24,741
7,543
3,578
4,658
30,604
61
514
1,135
60,049
營業費用
27,83432,49632,09155,122-77,197---84,011
研發費用
17,60027,40419,77516,18126,59348,61147,63954,21048,78769,556
推銷及管理費用
10,23411,35312,31612,85913,37516,35418,08818,20619,33914,455
非經常性項目費用
--6,261-26,08240,85312,232----
其他營業費用
----------
營業利益
-25,003
-7,755
-24,548
-51,544
-76,163
-46,593
-65,666
-71,902
-66,991
-23,962
其他收入及費用
1,0931,6711,8303292,2911,1983,5254,2955,0415,088
利息費用
1,072-4642,3992,0202,216-----
稅前純益
-24,982
-5,620
-25,117
-53,235
-76,088
-45,395
-62,141
-67,607
-61,950
-18,874
所得稅
----------
稅後純益
-24,982
-5,620
-25,117
-53,235
-76,088
-45,395
-62,141
-67,607
-61,950
-18,874
基本每股稅後盈餘(元)
-0.26-0.06-0.28-0.63-0.92-0.55-0.75-0.82-0.76-0.23
稀釋每股稅後盈餘(元)
-0.26--0.26-0.62-0.92-0.55-0.75-0.82-0.76-0.21
基本平均股數(千股)
97879.0097255.0090090.0084412.0083055.0082613.0082485.0082310.0081938.0081710.00
稀釋平均股數(千股)
97879.0097255.0090090.0084412.0083055.0082613.0082485.0082310.0081938.0081710.00
還原基本每股稅後盈餘(元)
-0.26-0.06-0.28-0.63-0.92-0.55-0.75-0.82-0.76-0.23
還原稀釋每股稅後盈餘(元)
-0.26--0.26-0.62-0.92-0.55-0.75-0.82-0.76-0.21
還原基本平均股數(千股)
97,87997,25590,09084,41283,05582,61382,48582,31081,93881,710
還原稀釋平均股數(千股)
97,87997,25590,09084,41283,05582,61382,48582,31081,93881,710
EBITDA(千元)
-23,427-5,279-22,059-49,638-72,538-44,883-61,868-68,067-62,257-19,511

大家都在看

HOT